Response Genetics Stock Net Income
| RGDXQ Stock | USD 0.0001 0.00 0.00% |
Response Genetics' fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Response Pink Sheet price.
Response |
Response Genetics Company Net Income Analysis
Response Genetics' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Response Genetics Net Income | (20.18 M) |
Most of Response Genetics' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Response Genetics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Response Genetics reported net income of (20.18 Million). This is 105.91% lower than that of the Life Sciences Tools & Services sector and 111.66% lower than that of the Health Care industry. The net income for all United States stocks is 103.53% higher than that of the company.
Response Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Response Genetics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Response Genetics could also be used in its relative valuation, which is a method of valuing Response Genetics by comparing valuation metrics of similar companies.Response Genetics is currently under evaluation in net income category among its peers.
Response Fundamentals
| Return On Asset | -0.68 | |||
| Profit Margin | (0.86) % | |||
| Operating Margin | (0.82) % | |||
| Current Valuation | 9.24 M | |||
| Shares Outstanding | 38.8 M | |||
| Number Of Shares Shorted | 78.1 K | |||
| Revenue | 18.04 M | |||
| Gross Profit | 6.23 M | |||
| EBITDA | (19.36 M) | |||
| Net Income | (20.18 M) | |||
| Cash And Equivalents | 1.73 M | |||
| Cash Per Share | 0.05 X | |||
| Total Debt | 10.94 M | |||
| Current Ratio | 1.79 X | |||
| Book Value Per Share | (0.13) X | |||
| Cash Flow From Operations | (13.6 M) | |||
| Short Ratio | 0.31 X | |||
| Earnings Per Share | (0.37) X | |||
| Target Price | 1.8 | |||
| Number Of Employees | 96 | |||
| Beta | 2.09 | |||
| Market Capitalization | 116 | |||
| Total Asset | 48.88 M | |||
| Retained Earnings | (83.02 M) | |||
| Working Capital | 3.88 M | |||
| Current Asset | 8.76 M | |||
| Current Liabilities | 4.88 M | |||
| Z Score | -1.4 | |||
| Net Asset | 48.88 M |
About Response Genetics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Response Genetics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Response Genetics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Response Genetics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Additional Tools for Response Pink Sheet Analysis
When running Response Genetics' price analysis, check to measure Response Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Response Genetics is operating at the current time. Most of Response Genetics' value examination focuses on studying past and present price action to predict the probability of Response Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Response Genetics' price. Additionally, you may evaluate how the addition of Response Genetics to your portfolios can decrease your overall portfolio volatility.